Evidence map›Paper›PMID 25035079›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2015

Amylin modulates the mesolimbic dopamine system to control energy balance.

Elizabeth G Mietlicki-Baase, David J Reiner, Jackson J Cone, Diana R Olivos, Lauren E McGrath, Derek J Zimmer, Mitchell F Roitman, Matthew R Hayes

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it, 114 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Amylin: A Multi-Functional Pancreatic Hormone-A Review.Diabetes, obesity & metabolism · 2026
    Review
  5. Article
  6. The evolving landscape of obesity pharmacotherapy.Nature reviews. Drug discovery · 2026
    Review
  7. Article
  8. Brain Amylin Signaling, Feeding, and Reward.Comprehensive Physiology · 2026
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Elizabeth G Mietlicki-BaaseTranslational Neuroscience Program, Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
David J ReinerTranslational Neuroscience Program, Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Jackson J ConeDepartment of Psychology, University of Illinois at Chicago, Chicago, IL, USA.
Diana R OlivosTranslational Neuroscience Program, Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Lauren E McGrathTranslational Neuroscience Program, Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Derek J ZimmerTranslational Neuroscience Program, Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Mitchell F RoitmanDepartment of Psychology, University of Illinois at Chicago, Chicago, IL, USA.
Matthew R HayesTranslational Neuroscience Program, Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
University of Pennsylvania · USUniversity of Illinois Chicago · US

Funding

Modulation of NAc-DA Signaling by Learning Motivational State and PeptidesR01DA025634 · NIDA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ROITMAN, MITCHELL F · 2009 to 2024
$5.1M
Neuroendocrinology of Energy Balance ControlR01DK096139 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI HAYES, MATTHEW R · 2012 to 2016
$1.7M
Glucagon-like peptide-1 in brainstem integration of energy balance controlF32DK097954 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI MIETLICKI-BAASE, ELIZABETH GENEVIEVE · 2013 to 2014
$82k
NIDA NIH HHS DA025634NIDA NIH HHS R01 DA025634NIDDK NIH HHS DK096139NIDDK NIH HHS DK097954NIDDK NIH HHS F32 DK097954NIDDK NIH HHS R01 DK096139
6 · The paper itself

Abstract

Amylin acts in the CNS to reduce feeding and body weight. Recently, the ventral tegmental area (VTA), a mesolimbic nucleus important for food intake and reward, was identified as a site-of-action mediating the anorectic effects of amylin. However, the long-term physiological relevance and mechanisms mediating the intake-suppressive effects of VTA amylin receptor (AmyR) activation are unknown. Data show that the core component of the AmyR, the calcitonin receptor (CTR), is expressed on VTA dopamine (DA) neurons and that activation of VTA AmyRs reduces phasic DA in the nucleus accumbens core (NAcC). Suppression in NAcC DA mediates VTA amylin-induced hypophagia, as combined NAcC D1/D2 receptor agonists block the intake-suppressive effects of VTA AmyR activation. Knockdown of VTA CTR via adeno-associated virus short hairpin RNA resulted in hyperphagia and exacerbated body weight gain in rats maintained on high-fat diet. Collectively, these findings show that VTA AmyR signaling controls energy balance by modulating mesolimbic DA signaling.

Indexed as

Amylin Receptor AgonistsAnimalsAppetite DepressantsDiet, High-FatDopamineEatingIslet Amyloid PolypeptideMaleNeuronsRats, Sprague-DawleyReceptors, CalcitoninReceptors, Dopamine D1Receptors, Dopamine D2Receptors, Islet Amyloid PolypeptideRNA, MessengerVentral Tegmental AreaAmylin Receptor AgonistsAppetite DepressantsDopamineIslet Amyloid PolypeptideReceptors, CalcitoninReceptors, Dopamine D1Receptors, Dopamine D2Receptors, Islet Amyloid PolypeptideRNA, Messenger

Identifiers

PMID25035079
PMCPMC4443949
OpenAlexW2057251250

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.